AFG
AMAG

American Financial Group’s AMAG Pharmaceuticals AMAG Stock Holding History

American Financial Group’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-30,000
Closed -$346K – 140
2019
Q3 		$346K Hold
30,000
– – 0.03% 124
2019
Q2 		$300K Buy
+30,000
New +$324K 0.02% 130

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

American Financial Group's AMAG Position: Q4 2019 in Review

American Financial Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2019, closing a stake of 30,000 shares — an estimated $346K sold.

American Financial Group first reported a position in AMAG in Q2 2019 and held it in 2 quarters. The position peaked at $346K in Q3 2019. 134 funds tracked by Wall St. Rank hold AMAG as of Q4 2019.

  • American Financial Group reported no remaining AMAG Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • American Financial Group sold 30,000 AMAG Pharmaceuticals shares in Q4 2019, an estimated $346K.
  • American Financial Group first reported a position in AMAG Pharmaceuticals in Q2 2019 and held it in 2 quarters.
  • American Financial Group's AMAG Pharmaceuticals position peaked at $346K in Q3 2019.
  • 134 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2019.

Based on American Financial Group's 13F filing for Q4 2019, filed 11 Feb 2020.